Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
暂无分享,去创建一个
R. Dockhorn | T. Reiss | S Shingo | B Seidenberg | T F Reiss | P Chervinsky | R J Dockhorn | T B Edwards | P. Chervinsky | B. Seidenberg | S. Shingo | T. B. Edwards | R. Dockhorn | P. Chervinsky | Sumiko Shingo | Thomas B. Edwards
[1] R Horne,et al. Compliance in asthma. , 1999, Respiratory medicine.
[2] T. Reiss,et al. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. , 1998, The Journal of allergy and clinical immunology.
[3] T. Reiss,et al. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. , 1998, The European respiratory journal.
[4] N. Santanello,et al. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. , 1997, The European respiratory journal.
[5] P. O'Byrne,et al. Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast. , 1997, The Journal of allergy and clinical immunology.
[6] M. Decramer,et al. Montelukast causes prolonged, potent leukotriene D4‐receptor antagonism in the airways of patients with asthma , 1997, Clinical pharmacology and therapeutics.
[7] J Zhang,et al. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. , 1997, Thorax.
[8] J Zhang,et al. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma. , 1996, The Journal of allergy and clinical immunology.
[9] E. Israel,et al. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. , 1996, JAMA.
[10] John L. Hankinson,et al. Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[11] J. Evans,et al. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. , 1995, Canadian journal of physiology and pharmacology.
[12] Goldstein Ra,et al. NIH conference. Asthma. , 1994 .
[13] S. Spector,et al. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. , 1994, American journal of respiratory and critical care medicine.
[14] J. Oates,et al. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. , 1994, American journal of respiratory and critical care medicine.
[15] G H Guyatt,et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.
[16] W. Busse,et al. The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma , 1993, Annals of Internal Medicine.
[17] K. Offord,et al. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. , 1993, Pediatrics.
[18] T. Haahtela,et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways , 1993, The Lancet.
[19] A. Hoffbrand,et al. Do leukotrienes play a role in the regulation of proliferation of normal and leukemic hemopoietic cells? , 1993, Prostaglandins, leukotrienes, and essential fatty acids.
[20] P. Gergen,et al. An economic evaluation of asthma in the United States. , 1992, The New England journal of medicine.
[21] G. Guyatt,et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. , 1992, Thorax.
[22] T. Petty,et al. Cromolyn sodium is effective in adult chronic asthmatics. , 1989, The American review of respiratory disease.
[23] Buist As. Standardization of spirometry. , 1987 .
[24] E. R. Mcfadden,et al. Effects of leukotriene D on the airways in asthma. , 1983, The New England journal of medicine.
[25] S. Langlois,et al. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. , 1982, British journal of clinical pharmacology.
[26] R. Rangno,et al. Mechanism of Propranolol Withdrawal Phenomena , 1979, Circulation.
[27] P. Molinoff,et al. In vitro study of beta-adrenergic receptors. , 1977, Annual review of pharmacology and toxicology.